MedTrace Logo

Aerobic Exercise in Patients Receiving Chemotherapy for Cancer

NCT00728429 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2017-05-30

No results posted yet for this study

Summary

RATIONALE: Aerobic exercise may help prevent side effects caused by chemotherapy and help improve heart health.

PURPOSE: This randomized clinical trial is studying the side effects of aerobic exercise and to see how well it works in patients receiving chemotherapy for cancer.

Conditions

  • Cardiac Toxicity
  • Chemotherapeutic Agent Toxicity
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BEHAVIORAL

exercise intervention

24 week program of exercise

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Gretchen Wells, MD, PhD · Wake Forest University Health Sciences

  • Peter H. Brubaker, PhD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00728429 on ClinicalTrials.gov